Company profilePharmaceutical#738 of 1,318 in Pakistan✓ No DRAP alerts

VARIOLINE INTERNATIONAL (PVT) LTD.

Pharmaceutical company · 12 brands · 14 molecules

Ranked #48 of 51 companies in Antimycotics Systemic Use

12 registered products 13 pharmaceutical brands 14 distinct molecules 0 DRAP alerts

Company overview

12
registered products
13
pharmaceutical brands
14
distinct molecules
2
therapeutic classes
0
DRAP alerts

VARIOLINE INTERNATIONAL (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 12 product registrations across 14 distinct molecules. Its portfolio is concentrated in Antimycotics Systemic Use and Antifungal For Dermatological. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Miconazole2 brands
Itraconazole ...... 100 Mg1 brand
Piroxicam1 brand
Coal Tar1 brand
Pine Tar1 brand
Cade Oil1 brand

Therapeutic classes

Antimycotics Systemic Use · 1Antifungal For Dermatological · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official2 products · Rs 54.57 – Rs 598.41
DVAGO1 products · Rs 400 – Rs 400
Median across source: Rs 400

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

VALOR PHARMACEUTICALS7 shared molecules
DERMA TECHNO PAKISTAN7 shared molecules
BIO LABS (PVT) LTD.6 shared molecules
SHROOQ PHARMACEUTICALS6 shared molecules
NEUTRO PHARMA (PVT) LTD.6 shared molecules
PEARL PHARMACEUTICALS6 shared molecules

Get the full profile for VARIOLINE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.